CAPR Operating Income Growth
Capricor Therapeutics Inc · Operating Income Growth
CAPR Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-84.12%period ending
CAPR TTM Operating Income YoY % (20.28% → -84.12%)
Year-over-year change
High-resolution chart · PNG
CAPR operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -84.1173% | |
| -109.3744% | |
| -154.0682% | |
| -139.801% | |
| -144.6748% | |
| -118.9754% | |
| -76.78% | |
| -17.1253% | |
| 1.5522% | |
| 12.9499% | |
| 18.9226% | |
| -10.1827% | |
| -17.9073% | |
| -27.2849% | |
| -41.8319% | |
| -49.4753% | |
| -40.9437% | |
| -41.0029% | |
| -52.9473% | |
| -70.4692% | |
| -110.6289% | |
| -129.8398% | |
| -77.0018% | |
| -15.0235% | |
| 28.0496% | |
| 48.6908% | |
| 49.5376% | |
| 37.54% | |
| 12.1014% | |
| -9.3584% | |
| -19.1557% | |
| -22.4472% | |
| 8.8157% | |
| 20.5009% | |
| 24.2283% | |
| 27.9686% | |
| -0.9292% | |
| -21.7913% | |
| -34.5913% | |
| -54.9759% | |
| -52.208% | |
| -62.6122% | |
| -109.6576% | |
| -71.9244% | |
| -50.7362% | |
| -23.9068% | |
| 12.8369% | |
| -33.9564% | |
| -65.3627% | |
| -114.5495% | |
| -182.9012% | |
| -28.4095% | |
| 9.6687% | |
| 30.621% | |
| 50.1996% | |
| 11.4991% | |
| 11.5348% | |
| 19.5162% | |
| 22.164% | |
| 37.3609% | |
| 29.845% | |
| 30.8478% | |
| 20.1573% | |
| 26.6201% | |
| 34.043% | |
| 33.1196% | |
| 41.176% | |
| 29.094% | |
| 25.869% | |
| -0.4012% | |
| -41.0483% | |
| -93.2934% | |
| -389.7248% | |
| -697.4616% | |
| -1,099.0565% | |
| -759.0676% | |
| -33,532.8868% | |
| -7,145.2789% | |
| -4,101.1187% | |
| -3,499.2804% | |
| 60.3694% | |
| 5.7364% | |
| 0.9661% | |
| -53.9978% | |
| -103.6034% | |
| -47.2679% | |
| -17.8673% | |
| 1.9395% | |
| 52.9844% | |
| 46.1377% | |
| 9.1277% | |
| 13.6528% | |
| -76.8593% | |
| -297.2884% | |
| 20.2753% |